chitosan has been researched along with Emesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elmotasem, H; Salama, AAA; Salama, AH | 1 |
| Jee, JP; Kim, CK; Kim, HT; Park, DM; Song, YK | 1 |
2 other study(ies) available for chitosan and Emesis
| Article | Year |
|---|---|
Nanotechnology based blended chitosan-pectin hybrid for safe and efficient consolidative antiemetic and neuro-protective effect of meclizine hydrochloride in chemotherapy induced emesis.
Topics: Administration, Buccal; Animals; Antiemetics; Antineoplastic Agents; Chemistry, Pharmaceutical; Chitosan; Cyclophosphamide; Cytokines; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Humans; Hydrogen-Ion Concentration; Inflammation Mediators; Male; Meclizine; Microscopy, Electron, Transmission; Nanoparticles; Neurotransmitter Agents; Oral Mucosal Absorption; Pectins; Rats; Rats, Wistar; Sheep; Spectroscopy, Fourier Transform Infrared; Tensile Strength; Vomiting | 2020 |
Development of chitosan-based ondansetron buccal delivery system for the treatment of emesis.
Topics: Absorption; Adhesiveness; Administration, Buccal; Animals; Antiemetics; Biological Availability; Chitosan; Cricetinae; Drug Compounding; Excipients; Gels; Half-Life; Male; Mesocricetus; Mouth Mucosa; Ondansetron; Pharmaceutical Vehicles; Serotonin 5-HT3 Receptor Antagonists; Solubility; Vomiting | 2012 |